Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 29, 2006Gobierno de Puerto Rico aprueba el Sistema Precision, que brinda a los médicos una nueva opción de tratamiento para dolor agudo y crónico
Boston Scientific Corporation (NYSE: BSX) anunció hoy sobre el primer paciente implantado en Puerto Rico con el Precision Spinal Cord Stimulation...
-
Sep 28, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it plans to adopt the recommendations announced today by the Heart Rhythm Society...
-
Sep 27, 2006
Boston Scientific Corporation (NYSE: BSX) today announced the approval of its new Harmony™ HiResolution® Bionic Ear System (Harmony System) by...
-
Sep 26, 2006CryoPlasty® Therapy may be an alternative to surgery or limb amputation
Boston Scientific Corporation (NYSE: BSX) today announced excellent six-month results from its Below-The-Knee (BTK) CHILL trial. This study, a...
-
Sep 21, 2006
Boston Scientific Corporation (NYSE: BSX) today announced preliminary net sales and earnings for its third quarter ending September 30, 2006....
-
Sep 19, 2006FLEXView™ System enables physicians to perform less-invasive cardiac surgical ablation procedures
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. market launch of the FLEXView™ System for unilateral visualization and...
-
Sep 14, 2006
Boston Scientific Corporation (NYSE: BSX) today issued the following comment on the statement of the U.S. Food and Drug Administration on...
-
Sep 13, 2006
Boston Scientific Corporation (NYSE: BSX) today welcomed the results of two studies and an editorial published in today's edition of The New...
-
Sep 6, 2006Overall cardiac death rate for combined bare-metal control group equivalent to TAXUS slow- and moderate-release formulations
Boston Scientific Corporation (NYSE: BSX) today announced four-year follow-up data from its TAXUS II paclitaxel-eluting stent system...
-
Sep 5, 2006Initial six-month results show positive outcomes in diabetic patients; safety events for diabetic subset lower than overall patient population
Boston Scientific Corporation (NYSE: BSX) today announced six-month results from Phase I of its global TAXUS OLYMPIA registry,...